ATE522546T1 - Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet - Google Patents
Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindetInfo
- Publication number
- ATE522546T1 ATE522546T1 AT04732278T AT04732278T ATE522546T1 AT E522546 T1 ATE522546 T1 AT E522546T1 AT 04732278 T AT04732278 T AT 04732278T AT 04732278 T AT04732278 T AT 04732278T AT E522546 T1 ATE522546 T1 AT E522546T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- monoclonal antibodies
- probnp
- native probnp
- binds amino
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title 1
- 102100036836 Natriuretic peptides B Human genes 0.000 abstract 5
- 101710187802 Natriuretic peptides B Proteins 0.000 abstract 5
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03010591 | 2003-05-12 | ||
PCT/EP2004/005091 WO2004099252A1 (en) | 2003-05-12 | 2004-05-12 | Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE522546T1 true ATE522546T1 (de) | 2011-09-15 |
Family
ID=33427054
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04732278T ATE522546T1 (de) | 2003-05-12 | 2004-05-12 | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet |
AT04732282T ATE517124T1 (de) | 2003-05-12 | 2004-05-12 | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 42- 46 bindet |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04732282T ATE517124T1 (de) | 2003-05-12 | 2004-05-12 | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 42- 46 bindet |
Country Status (16)
Country | Link |
---|---|
US (4) | US7264938B2 (de) |
EP (4) | EP1625164B1 (de) |
JP (4) | JP4430066B2 (de) |
KR (2) | KR20080011467A (de) |
CN (3) | CN100497393C (de) |
AT (2) | ATE522546T1 (de) |
AU (1) | AU2004235974B2 (de) |
BR (1) | BRPI0410261B8 (de) |
CA (2) | CA2522747C (de) |
DK (3) | DK2256132T3 (de) |
ES (3) | ES2372282T3 (de) |
HK (1) | HK1097855A1 (de) |
HU (1) | HUE025169T2 (de) |
MX (1) | MXPA05011826A (de) |
PL (3) | PL2256132T3 (de) |
WO (2) | WO2004099252A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2843396B1 (fr) * | 2002-08-07 | 2005-04-15 | Bio Rad Pasteur | Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque |
ATE522546T1 (de) * | 2003-05-12 | 2011-09-15 | Hoffmann La Roche | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet |
WO2004105575A2 (en) * | 2003-05-29 | 2004-12-09 | Trustee Of Darmouth College | A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
DE10355731A1 (de) | 2003-11-28 | 2005-06-30 | Roche Diagnostics Gmbh | Analytischer Sandwichtest zur Bestimmung von NT-proBNP |
ES2288718T3 (es) * | 2004-07-07 | 2008-01-16 | F. Hoffmann-La Roche Ag | Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2. |
AT500800B1 (de) * | 2004-09-08 | 2008-07-15 | Biomedica Medizinprodukte Gmbh | Verfahren zur bestimmung von probnp |
JP2010517023A (ja) | 2007-01-25 | 2010-05-20 | エフ.ホフマン−ラ ロシュ アーゲー | 心不全の評価におけるigfbp−7の使用 |
KR100836322B1 (ko) * | 2007-08-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 흡음재 제작장치 및 방법 |
US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
CN102027374A (zh) | 2008-04-30 | 2011-04-20 | 霍夫曼-拉罗奇有限公司 | Sfrp-3在评价心力衰竭中的用途 |
CN102549436A (zh) | 2009-07-27 | 2012-07-04 | 霍夫曼-拉罗奇有限公司 | mimecan在评价心力衰竭中的用途 |
JP5728488B2 (ja) * | 2009-11-13 | 2015-06-03 | ビージー メディシン, インコーポレイテッド | 心筋梗塞のリスクファクターおよび予測 |
CA2807240A1 (en) | 2010-08-04 | 2012-02-09 | Idexx Laboratories, Inc. | Detection of degradation products of canine nt-probnp |
AU2012262154B2 (en) | 2011-05-31 | 2016-08-04 | Idexx Laboratories, Inc. | Detection of degradation products of feline NT-proBNP |
WO2013042603A1 (ja) * | 2011-09-20 | 2013-03-28 | コニカミノルタホールディングス株式会社 | 検体希釈用液、それを用いたキットおよび蛍光測定方法 |
US20140273273A1 (en) | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
CN103304665A (zh) * | 2013-05-21 | 2013-09-18 | 上海贝西生物科技有限公司 | 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用 |
SG11201702490PA (en) | 2014-10-10 | 2017-04-27 | Akira Matsumori | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure |
EP3360570A1 (de) | 2017-02-13 | 2018-08-15 | Roche Diagnostics GmbH | Monoklonale antikörper für nt-probnp punktmutationen |
JP7203034B2 (ja) * | 2017-10-02 | 2023-01-12 | 大塚製薬株式会社 | アナライトの検出方法 |
CN108752480B (zh) * | 2018-05-30 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 一种免疫原组合物、其制备方法及其用途 |
US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
CN111487222B (zh) * | 2019-01-28 | 2023-11-14 | 上海乐合生物科技有限公司 | 一种检测bnp的spr芯片的制备方法 |
EP4014041A1 (de) | 2019-08-13 | 2022-06-22 | Gentian AS | Hochempfindliches partikelverstärktes assay zur quantifizierung von nt-probnp |
EP4222499A1 (de) | 2020-09-30 | 2023-08-09 | F. Hoffmann-La Roche AG | Zirkulierendes total-nt-probnp (glycosyliertes und unglycosyliertes nt-probnp) und sein verhältnis mit nt-probnp (unglycosyliertem nt-probnp) bei der beurteilung von vorhofflimmern |
CN112986586A (zh) * | 2021-02-20 | 2021-06-18 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
CN112964885B (zh) * | 2021-02-20 | 2022-11-11 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
WO2023052642A1 (en) | 2021-10-01 | 2023-04-06 | Gentian As | Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sample |
WO2023175152A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
WO2023175176A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | hBNPのC端を認識するモノクロ−ナル抗体 |
GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
GB9827348D0 (en) * | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
DE50015291D1 (de) * | 1999-01-29 | 2008-09-11 | Roche Diagnostics Gmbh | Verfahren zum Nachweis von N-terminalem proBNP |
US20030219734A1 (en) | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
US20040096919A1 (en) * | 2002-11-18 | 2004-05-20 | Michelle Davey | Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
ATE522546T1 (de) * | 2003-05-12 | 2011-09-15 | Hoffmann La Roche | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet |
-
2004
- 2004-05-12 AT AT04732278T patent/ATE522546T1/de active
- 2004-05-12 DK DK10172014.2T patent/DK2256132T3/en active
- 2004-05-12 ES ES04732278T patent/ES2372282T3/es not_active Expired - Lifetime
- 2004-05-12 HU HUE10172014A patent/HUE025169T2/en unknown
- 2004-05-12 AT AT04732282T patent/ATE517124T1/de active
- 2004-05-12 ES ES10172014.2T patent/ES2548327T3/es not_active Expired - Lifetime
- 2004-05-12 EP EP04732282A patent/EP1625164B1/de not_active Expired - Lifetime
- 2004-05-12 KR KR1020087000782A patent/KR20080011467A/ko not_active Application Discontinuation
- 2004-05-12 CA CA2522747A patent/CA2522747C/en not_active Expired - Lifetime
- 2004-05-12 EP EP04732278A patent/EP1625163B8/de not_active Expired - Lifetime
- 2004-05-12 MX MXPA05011826A patent/MXPA05011826A/es active IP Right Grant
- 2004-05-12 PL PL10172014T patent/PL2256132T3/pl unknown
- 2004-05-12 AU AU2004235974A patent/AU2004235974B2/en not_active Expired
- 2004-05-12 DK DK04732282.1T patent/DK1625164T3/da active
- 2004-05-12 PL PL04732282T patent/PL1625164T3/pl unknown
- 2004-05-12 ES ES04732282T patent/ES2369008T3/es not_active Expired - Lifetime
- 2004-05-12 CN CNB200480012494XA patent/CN100497393C/zh not_active Expired - Lifetime
- 2004-05-12 WO PCT/EP2004/005091 patent/WO2004099252A1/en active Application Filing
- 2004-05-12 PL PL04732278T patent/PL1625163T3/pl unknown
- 2004-05-12 BR BRPI0410261A patent/BRPI0410261B8/pt active IP Right Grant
- 2004-05-12 CN CN2010101190838A patent/CN101967190A/zh active Pending
- 2004-05-12 CA CA2522378A patent/CA2522378C/en not_active Expired - Lifetime
- 2004-05-12 EP EP10172014.2A patent/EP2256132B1/de not_active Expired - Lifetime
- 2004-05-12 EP EP15161853.5A patent/EP2949669A1/de not_active Ceased
- 2004-05-12 CN CNA2004800124973A patent/CN1784425A/zh active Pending
- 2004-05-12 JP JP2006505418A patent/JP4430066B2/ja not_active Expired - Lifetime
- 2004-05-12 KR KR1020057021327A patent/KR100857752B1/ko active IP Right Grant
- 2004-05-12 JP JP2006505419A patent/JP5128125B2/ja not_active Expired - Lifetime
- 2004-05-12 DK DK04732278.9T patent/DK1625163T3/da active
- 2004-05-12 WO PCT/EP2004/005092 patent/WO2004099253A1/en active Search and Examination
-
2005
- 2005-11-10 US US11/271,138 patent/US7264938B2/en not_active Expired - Lifetime
- 2005-11-10 US US11/271,651 patent/US7264939B2/en not_active Expired - Lifetime
-
2006
- 2006-12-05 US US11/634,286 patent/US7807380B2/en not_active Expired - Lifetime
- 2006-12-22 US US11/644,565 patent/US7811770B2/en not_active Expired - Lifetime
-
2007
- 2007-02-28 HK HK07102250.4A patent/HK1097855A1/xx not_active IP Right Cessation
-
2009
- 2009-09-04 JP JP2009204610A patent/JP4834136B2/ja not_active Expired - Lifetime
-
2012
- 2012-10-04 JP JP2012222436A patent/JP5649631B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE522546T1 (de) | Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38- 43 bindet | |
PE20090722A1 (es) | Hepcidina, antagonistas de la hepcidina y metodos de uso | |
ATE480562T1 (de) | Veränderung von fcrn-bindungsaffinitäten oder von serumhalbwertszeiten von antikörpern mittels mutagenese | |
RS54113B1 (en) | COMPOSITIONS AND PROCEDURES FOR ANTIBODIES ON THE C5 COMPLEMENTARY PROTEIN | |
ATE440868T1 (de) | Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
DE50014666D1 (de) | VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP | |
DE602004001533D1 (de) | Immunotestverfahren für Herz-Troponin I | |
RU2010133547A (ru) | Анти-cldn антитела | |
DE60334696D1 (de) | Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt | |
ATE554390T1 (de) | Verfahren zur gewinnung von antikörpern | |
ATE523523T1 (de) | Monoklonale anti minichomosome maintenance 2 protein antikörper und verfahren zu deren verwendung beim nachweis einer zervikalen erkrankung | |
DE50304608D1 (de) | Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden | |
DE60014124D1 (de) | Antikörper, die spezifisch für fullerene sind | |
ATE511650T1 (de) | Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper | |
ATE513215T1 (de) | Monoklonale antikörper, hybridomzellinien, verfahren und kits zum nachweis von phytase | |
ATE535546T1 (de) | Humane monoklonale antikörper, die spezifisch an ifg-ii binden | |
JP3996137B2 (ja) | 抗重金属モノクローナル抗体およびその使用方法 | |
WO2009044561A1 (ja) | 抗proNT/NMNモノクローナル抗体 | |
WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
SE0202702L (sv) | Immunotest för specifik bestämning av SCCA isoformer | |
DE69919859D1 (de) | Verfahren zum bestimmen eines überschäumfaktors für ein getränk | |
PE20191840A1 (es) | Kit diagnostico diferencial y rapido para deteccion de la coriza infecciosa y el sindrome de cabeza hinchada en la industria avicola | |
ATE111226T1 (de) | Verfahren zum nachweis von analyten. | |
ATE405646T1 (de) | Ein verfahren zum auffinden vom prostatakrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1625163 Country of ref document: EP |